<code id='15A2840608'></code><style id='15A2840608'></style>
    • <acronym id='15A2840608'></acronym>
      <center id='15A2840608'><center id='15A2840608'><tfoot id='15A2840608'></tfoot></center><abbr id='15A2840608'><dir id='15A2840608'><tfoot id='15A2840608'></tfoot><noframes id='15A2840608'>

    • <optgroup id='15A2840608'><strike id='15A2840608'><sup id='15A2840608'></sup></strike><code id='15A2840608'></code></optgroup>
        1. <b id='15A2840608'><label id='15A2840608'><select id='15A2840608'><dt id='15A2840608'><span id='15A2840608'></span></dt></select></label></b><u id='15A2840608'></u>
          <i id='15A2840608'><strike id='15A2840608'><tt id='15A2840608'><pre id='15A2840608'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:63352
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          BMS, looking to build heart drug business, turns to AI for diagnosis
          BMS, looking to build heart drug business, turns to AI for diagnosis

          AdobeAsBristolMyersSquibbworkstobuilditstreatmentforaheartconditionthatcancausedifficultybreathingin

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Keeping primary care docs in field isn't impossible, says AAFP CEO

          R.ShawnMartin,theCEOoftheAmericanAcademyofFamilyPhysiciansCourtesyAmericanAcademyofFamilyPhysiciansI